Author
Listed:
- Alan Storey
(Imperial Cancer Research Fund, Skin Tumour Laboratory)
- Miranda Thomas
(International Centre for Genetic Engineering and Biotechnology)
- Ann Kalita
(International Centre for Genetic Engineering and Biotechnology)
- Catherine Harwood
(Imperial Cancer Research Fund, Skin Tumour Laboratory)
- Daniela Gardiol
(International Centre for Genetic Engineering and Biotechnology)
- Fiamma Mantovani
(International Centre for Genetic Engineering and Biotechnology)
- Judith Breuer
(St Bartholomews and The Royal London Hospital School of Medicine and Dentistry, Queen Mary and Westfield College)
- Irene M. Leigh
(Imperial Cancer Research Fund, Skin Tumour Laboratory)
- Greg Matlashewski
(Institute of Parasitology and McGill Cancer Centre, McGill University, Macdonald Campus)
- Lawrence Banks
(Institute of Parasitology and McGill Cancer Centre, McGill University, Macdonald Campus)
Abstract
The E6 oncoprotein derived from tumour-associated human papillomaviruses (HPVs) binds to and induces the degradation of the cellular tumour-suppressor protein p53. A common polymorphism that occurs in the p53 amino-acid sequence results in the presence of either a proline or an arginine at position 72. The effect of this polymorphism on the susceptibility of p53 to E6-mediated degradation has been investigated and the arginine form of p53 was found to be significantly more susceptible than the proline form. Moreover, allelic analysis of patients with HPV-associated tumours revealed a striking overrepresentation of homozygous arginine-72 p53 compared with the normal population, which indicated that individuals homozygous for arginine 72 are about seven times more susceptible to HPV-associated tumorigenesis than heterozygotes. The arginine-encoding allele therefore represents a significant risk factor in the development of HPV-associated cancers.
Suggested Citation
Alan Storey & Miranda Thomas & Ann Kalita & Catherine Harwood & Daniela Gardiol & Fiamma Mantovani & Judith Breuer & Irene M. Leigh & Greg Matlashewski & Lawrence Banks, 1998.
"Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer,"
Nature, Nature, vol. 393(6682), pages 229-234, May.
Handle:
RePEc:nat:nature:v:393:y:1998:i:6682:d:10.1038_30400
DOI: 10.1038/30400
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:393:y:1998:i:6682:d:10.1038_30400. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.